Ken Y Thong

Clinical risk factors predicting genital fungal infections with sodium–glucose cotransporter 2 inhibitor treatment: The ABCD nationwide dapagliflozin audit

Ken Y Thong, MAHENDER YADAGIRI, Dennis Barnes et al. · Primary care diabetes · 2017 · 62 citations · Full text

Sodium–glucose Cotransporter 2, Genital Fungal Infections, Fungal Pathogen +9

Plastic in patient study: Prospective audit of adherence to peripheral intravenous cannula monitoring and documentation guidelines, with the aim of reducing future rates of intravenous cannula-related complications

Lokesh Yagnik, Angela Graves, Ken Y Thong · American Journal of Infection Control · 2016 · 35 citations

Patient Safety, Perioperative Safety, Outcomes Research +6

The influence of age and metformin treatment status on reported gastrointestinal side effects with liraglutide treatment in type 2 diabetes

Ken Y Thong, Piya Sen Gupta, AD Blann et al. · Diabetes Research and Clinical Practice · 2015 · 28 citations · Full text

Liraglutide Treatment, Metabolic Syndrome, Diabetes Management +7

GLP-1 receptor agonists in type 2 diabetes - NICE guidelines versus clinical practice

Ken Y Thong, Piya Sen Gupta, Melissa Cull et al. · The British Journal of Diabetes · 2014 · 27 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +13

Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit

Ken Y Thong, Biju Jose, AD Blann et al. · Diabetes Research and Clinical Practice · 2011 · 25 citations

Diabetes Management, Insulin Management, Diabetes +6